ARKETFTRUS > ARK ETF Trust
ARK Genomic Revolution ETF
$1.73B
Avg Monthly Net Assets
$1.47B
Total Assets
$5.57M
Total Liabilities
$1.46B
Net Assets
ARK Genomic Revolution ETF is an Exchange-Traded Fund in ARK ETF Trust
from ARKETFTRUS,
based in Florida,
United States of America.
The fund has one share class
and monthly net assets of $1.73B.
On September 26th, 2024 it reported 41 holdings, the largest
being Twist Bioscience Corp (9.8%), CRISPR Therapeutics AG (6.9%) and CareDx Inc (6.7%).
Data provided by Fincoded.
Share Classes
| Name | Class/Contract ID | Exchange | Ticker | Monthly Returns (2 years) |
|---|---|---|---|---|
| ARK Genomic Revolution ETF | C000133119 | XCBO | ARKG |
Holdings
From latest NPORT-P, filed September 26th, 2024 for period ending July 31st, 2024.
Historic holdings data available from Fincoded.
| Name | Profile | Category | Country | Value $USD | # Shares | % of Fund |
|---|---|---|---|---|---|---|
| 10X Genomics Inc | Long | Equity-common | US | $54M | 3M | 3.66 |
| 908 Devices Inc | Long | Equity-common | US | $23M | 4M | 1.55 |
| Absci Corp | Long | Equity-common | US | $25M | 6M | 1.71 |
| Accolade Inc | Long | Equity-common | US | $23M | 6M | 1.56 |
| Adaptive Biotechnologies Corp | Long | Equity-common | US | $55M | 12M | 3.74 |
| Amgen Inc | Long | Equity-common | US | $26M | 79K | 1.80 |
| Arcturus Therapeutics Holdings Inc | Long | Equity-common | US | $46M | 2M | 3.11 |
| Beam Therapeutics Inc | Long | Equity-common | US | $65M | 2M | 4.45 |
| Butterfly Network Inc | Long | Equity-common | US | $12M | 11M | 0.82 |
| CareDx Inc | Long | Equity-common | US | $97M | 5M | 6.65 |
| Cerus Corp | Long | Equity-common | US | $18M | 8M | 1.22 |
| Compass Pathways Plc | Long | Equity-common | GB | $16M | 2M | 1.08 |
| CRISPR Therapeutics AG | Long | Equity-common | CH | $101M | 2M | 6.92 |
| Exact Sciences Corp | Long | Equity-common | US | $16M | 339K | 1.06 |
| Ginkgo Bioworks Holdings Inc | Long | Equity-common | US | $8M | 21M | 0.54 |
| Goldman Sachs Financial Square Treasury Obligations Fund | Long | Short-term investment vehicle | US | $3M | 3M | 0.22 |
| Guardant Health Inc | Long | Equity-common | US | $29M | 833K | 2.00 |
| Incyte Corp | Long | Equity-common | US | $14M | 219K | 0.97 |
| Intellia Therapeutics Inc | Long | Equity-common | US | $70M | 3M | 4.76 |
| Ionis Pharmaceuticals Inc | Long | Equity-common | US | $67M | 1M | 4.55 |
| Moderna Inc | Long | Equity-common | US | $42M | 349K | 2.84 |
| Natera Inc | Long | Equity-common | US | $17M | 164K | 1.15 |
| Nurix Therapeutics Inc | Long | Equity-common | US | $50M | 2M | 3.43 |
| Pacific Biosciences of California Inc | Long | Equity-common | US | $26M | 13M | 1.79 |
| Personalis Inc | Long | Equity-common | US | $22M | 6M | 1.51 |
| Prime Medicine Inc | Long | Equity-common | US | $16M | 3M | 1.12 |
| Quantum-Si Inc | Long | Equity-common | US | $13M | 12M | 0.91 |
| Recursion Pharmaceuticals Inc | Long | Equity-common | US | $79M | 10M | 5.42 |
| Regeneron Pharmaceuticals Inc | Long | Equity-common | US | $17M | 16K | 1.16 |
| Repare Therapeutics Inc | Long | Equity-common | CA | $10M | 3M | 0.66 |
| Schrodinger Inc/United States | Long | Equity-common | US | $54M | 2M | 3.69 |
| Senti Biosciences Inc | Long | Equity-common | US | $415K | 180K | 0.03 |
| Standard BioTools Inc | Long | Equity-common | US | $28M | 13M | 1.92 |
| Teladoc Health Inc | Long | Equity-common | US | $12M | 1M | 0.85 |
| Tempus AI Inc | Long | Equity-common | US | $28M | 646K | 1.91 |
| Twist Bioscience Corp | Long | Equity-common | US | $143M | 3M | 9.76 |
| UiPath Inc | Long | Equity-common | US | $1K | 105 | 0.00 |
| Veeva Systems Inc | Long | Equity-common | US | $32M | 166K | 2.18 |
| Veracyte Inc | Long | Equity-common | US | $47M | 2M | 3.23 |
| Vertex Pharmaceuticals Inc | Long | Equity-common | US | $37M | 75K | 2.53 |
| Verve Therapeutics Inc | Long | Equity-common | US | $17M | 2M | 1.15 |
Address
ARK ETF Trust
200 Central Avenue
Suite 220
St. Petersburg
Florida
33701
United States of America
Websites
Directors
Catherine D. Wood
Scott R. Chichester
Darlene T. DeRemer
Robert G. Zack
Transfer Agents
The Bank of New York Mellon
Pricing Services
LSEG Data & Analytics
Bloomberg Finance L.P.
Intercontinental Exchange, Inc.
Custodians
Euroclear France
The Bank of New York Mellon, SA/NV (Italy)
HSBC Bank Australia Limited
Skandinaviska Enskilda Banken AB, Stockholm
HBTW
The Bank of New York Mellon, SA/NV (Netherlands)
CIBC Mellon Trust Company (Canada)
Credit Suisse (Switzerland) Ltd.
MUFG Bank, Ltd.
Citibank Europe Plc, Sucursal em Portugal
Banco Bilbao Vizcaya Argentaria SA
HSBC NOMINEES (NEW ZEALAND) LIMITED
The Bank of New York Mellon (Ireland)
Euroclear Bank
Skandinaviska Enskilda Banken AB, Oslo Branch
The Bank of New York Mellon SA/NV (Germany)
The Hongkong and Shanghai Banking Corporation (Hong Kong)
Skandinaviska Enskilda Banken AB, Helsinki Branch
The Bank of New York Mellon (United Kingdom)
Skandinaviska Enskilda Banken AB, Copenhagen Branch
Standard Chartered Bank (Singapore) Limited
Banque Nationale de Belgique SA/NV
Euroclear
Bank Hapoalim B.M.
UniCredit Bank Austria AG
The Bank of New York Mellon
Shareholder Servicing Agents
The Bank of New York Mellon
Admins
The Bank of New York Mellon
Brokers
VIRTU AMERICAS LLC
BTIG, LLC
BNY MELLON CAPITAL MARKETS, LLC